Attached files
| file | filename |
|---|---|
| EX-31.2 - CFO CERT - CHEMBIO DIAGNOSTICS, INC. | ex31_2q.htm |
| EX-31.1 - CEO CERT - CHEMBIO DIAGNOSTICS, INC. | ex31_1q.htm |
| 10-Q - FORM 10-Q SECOND QUARTER 2017 - CHEMBIO DIAGNOSTICS, INC. | form10q.htm |
EXHIBIT 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q (the "Report") of Chembio Diagnostics, Inc. (the "Company") for the quarter ended June 30, 2017, each of the undersigned Sharon Klugewicz, the acting Chief Executive Officer of the Company, and Richard J. Larkin, the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigneds' knowledge and belief:
(1) This Form 10-Q for the quarter ended June 30, 2017 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in this Form 10-Q for the quarter ended June 30, 2017 fairly presents, in all material respects, the financial condition and results of operations of Chembio Diagnostics, Inc. for the periods presented therein.
Dated: August 9, 2017 /s/ Sharon Klugewicz
Sharon Klugewicz
Chief Executive Officer
Dated: August 9, 2017 /s/ Richard J. Larkin
Richard J. Larkin
Chief Financial Officer